Attenuation of Hypertrophy in Human MSCs via Treatment with a Retinoic Acid Receptor Inverse Agonist

URN to cite this document:: urn:nbn:de:bvb:355-epub-430347
DOI to cite this document:: 10.5283/epub.43034

Riedl, Moritz

; Witzmann, Christina ; Koch, Matthias ; Lang, Siegmund ; Kerschbaum, Maximilian

; Baumann, Florian

; Krutsch, Werner ; Docheva, Denitsa

; Alt, Volker ; Pfeifer, Christian

Preview

License: Creative Commons Attribution 4.0
PDF - Published Version
(2MB)

Date of publication of this fulltext: 26 Mar 2020 15:18

Alternative links to fulltext:DOI Publisher

Details

Preview

Indexed in

Export bibliographical data

Abstract

In vitro chondrogenically differentiated mesenchymal stem cells (MSCs) have a tendency to undergo hypertrophy, mirroring the fate of transient "chondrocytes" in the growth plate. As hypertrophy would result in ossification, this fact limits their use in cartilage tissue engineering applications. During limb development, retinoic acid receptor (RAR) signaling exerts an important influence on cell ...